Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 14, 2011
Document Date
Dec 31, 2010
Form Description
Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act
Filing Group
Annual Filings
Company
Vericel Corporation
Issuer
VERICEL CORP

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.